Completed NA INTERVENTIONAL 2-arm NCT04539379

Evaluation of Intravenous Infusion of Labetalol Versus Magnesium Sulfate

Evaluation of Intravenous Infusion of Labetalol Versus Magnesium Sulfate on Cerebral Hemodynamics of Severe Preeclampsia Patients Using Transcranial Doppler

Sponsor: Zagazig University

Conditions Labetalol Magnesium Sulfate

Interventions Labetolol Magnesium sulfate

Updated 6 times since 2020 Last updated: Nov 13, 2022 Started: Oct 1, 2020 Primary completion: Feb 1, 2022 Completion: Mar 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Labetalol and Magnesium Sulfate, this trial is completed. The trial is conducted by Zagazig University and has accumulated 6 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2022 — Jul 2024 [monthly]

Completed NA
May 2021 — Dec 2022 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2021 — May 2021 [monthly]

Recruiting NA

▶ Show 1 earlier version

Oct 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zagazig University

Data source: Zagazig University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zagazig, Egypt